C10ORF10/DEPP, a transcriptional target of FOXO3, regulates ROS-sensitivity in human neuroblastoma

Molecular Cancer

Volumn 13, Issue 1, 2014, Pages

  Salcher, Stefan ^a,b   Hagenbuchner, Judith ^a,b   Geiger, Kathrin ^b   Seiter, Maximilian A ^a,b   Rainer, Johannes ^a,b   Kofler, Reinhard ^a,b   Hermann, Martin ^c   Kiechl Kohlendorfer, Ursula ^a   Ausserlechner, Michael J ^a,b   Obexer, Petra ^a,b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b TYROLEAN CANCER RESEARCH INSTITUTE   (Austria)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

DEPP; FOXO3; Peroxisomes; Reactive oxygen species

Indexed keywords

CATALASE; DECIDUAL PROTEIN INDUCED BY PROGESTERONE; ETOPOSIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROGESTERONE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG; BETA CATENIN; C10ORF10 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXO3 PROTEIN, HUMAN; HYDROGEN PEROXIDE; MESSENGER RNA; PROTEIN;

APOPTOSIS; ARTICLE; CELL DEATH; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; DECIDUALIZATION ASSAY; DETOXIFICATION; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; HUMAN; IMMUNOPRECIPITATION; MITOCHONDRION; NERVE CELL; NEUROBLASTOMA CELL; PEROXISOME; REGULATORY MECHANISM; SENSITIZATION; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION; BINDING SITE; BRAIN TUMOR; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETICS; HEK293 CELL LINE; METABOLISM; NEUROBLASTOMA; PATHOLOGY; PROMOTER REGION;

APOPTOSIS; BETA CATENIN; BINDING SITES; BRAIN NEOPLASMS; CATALASE; ETOPOSIDE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; HYDROGEN PEROXIDE; MITOCHONDRIA; NEUROBLASTOMA; PEROXISOMES; PROMOTER REGIONS, GENETIC; PROTEINS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 84907953853     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-13-224     Document Type: Article

References (46)

1. Kuroda Y, Kuriyama H, Kihara S, Kishida K, Maeda N, Hibuse T, Nishizawa H, Matsuda M, Funahashi T, Shimomura I. Insulin-mediated regulation of decidual protein induced by progesterone (DEPP) in adipose tissue and liver. Horm Metab Res 2010, 42:173-177. 10.1055/s-0029-1241841, 19937567.
2. Shin D, Anderson DJ. Isolation of arterial-specific genes by subtractive hybridization reveals molecular heterogeneity among arterial endothelial cells. Dev Dyn 2005, 233:1589-1604. 10.1002/dvdy.20479, 15977181.
3. Watanabe H, Nonoguchi K, Sakurai T, Masuda T, Itoh K, Fujita J. A novel protein Depp, which is induced by progesterone in human endometrial stromal cells activates Elk-1 transcription factor. Mol Hum Reprod 2005, 11:471-476. 10.1093/molehr/gah186, 16123073.
4. Arden KC, Biggs WH. Regulation of the FoxO family of transcription factors by phosphatidylinositol-3 kinase-activated signaling. Arch Biochem Biophys 2002, 403:292-298. 10.1016/S0003-9861(02)00207-2, 12139979.
5. Obexer P, Geiger K, Ambros PF, Meister B, Ausserlechner MJ. FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells. Cell Death Differ 2007, 14:534-547. 10.1038/sj.cdd.4402017, 16888645.
6. Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, Coffer PJ, Huang TT, Bos JL, Medema RH, Burgering BM. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 2002, 419:316-321. 10.1038/nature01036, 12239572.
7. Calnan DR, Brunet A. The FoxO code. Oncogene 2008, 27:2276-2288. 10.1038/onc.2008.21, 18391970.
8. Ho KK, Myatt SS, Lam EW. Many forks in the path: cycling with FoxO. Oncogene 2008, 27:2300-2311. 10.1038/onc.2008.23, 18391972.
9. Hagenbuchner J, Ausserlechner MJ. Mitochondria and FOXO3: breath or die. Front Psychol 2013, 4:147. 3612696, 23554597.
10. Obexer P, Hagenbuchner J, Unterkircher T, Sachsenmaier N, Seifarth C, Bock G, Porto V, Geiger K, Ausserlechner M. Repression of BIRC5/survivin by FOXO3/FKHRL1 sensitizes human neuroblastoma cells to DNA damage-induced apoptosis. Mol Biol Cell 2009, 20:2041-2048. 10.1091/mbc.E08-07-0699, 2663932, 19211844.
11. Hagenbuchner J, Kuznetsov A, Hermann M, Hausott B, Obexer P, Ausserlechner MJ. FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3. J Cell Sci 2012, 125:1191-1203. 10.1242/jcs.092098, 22349704.
12. Kim SJ, Yune TY, Han CT, Kim YC, Oh YJ, Markelonis GJ, Oh TH. Mitochondrial isocitrate dehydrogenase protects human neuroblastoma SH-SY5Y cells against oxidative stress. J Neurosci Res 2007, 85:139-152. 10.1002/jnr.21106, 17075901.
13. Sandalio LM, Rodriguez-Serrano M, Romero-Puertas MC, Del Rio LA. Role of Peroxisomes as a Source of Reactive Oxygen Species (ROS) Signaling Molecules. Subcell Biochem 2013, 69:231-255. 10.1007/978-94-007-6889-5_13, 23821152.
14. Rhee SG, Woo HA, Kil IS, Bae SH. Peroxiredoxin functions as a peroxidase and a regulator and sensor of local peroxides. J Biol Chem 2012, 287:4403-4410. 10.1074/jbc.R111.283432, 3281607, 22147704.
15. Walton PA, Pizzitelli M. Effects of peroxisomal catalase inhibition on mitochondrial function. Front Physiol 2012, 3:108. 3332217, 22536190.
16. Essers MA, Weijzen S, de Vries-Smits AM, Saarloos I, de Ruiter ND, Bos JL, Burgering BM. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J 2004, 23:4802-4812. 10.1038/sj.emboj.7600476, 535088, 15538382.
17. Tan WQ, Wang K, Lv DY, Li PF. Foxo3a inhibits cardiomyocyte hypertrophy through transactivating catalase. J Biol Chem 2008, 283:29730-29739. 10.1074/jbc.M805514200, 2662055, 18772130.
18. Devasagayam TP, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD. Free radicals and antioxidants in human health: current status and future prospects. J Assoc Physicians India 2004, 52:794-804.
19. Menon SG, Sarsour EH, Kalen AL, Venkataraman S, Hitchler MJ, Domann FE, Oberley LW, Goswami PC. Superoxide signaling mediates N-acetyl-L-cysteine-induced G1 arrest: regulatory role of cyclin D1 and manganese superoxide dismutase. Cancer Res 2007, 67:6392-6399. 10.1158/0008-5472.CAN-07-0225, 17616699.
20. Girnun GD, Domann FE, Moore SA, Robbins ME. Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. Mol Endocrinol 2002, 16:2793-2801. 10.1210/me.2002-0020, 12456800.
21. Armoni M, Harel C, Karni S, Chen H, Bar-Yoseph F, Ver MR, Quon MJ, Karnieli E. FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity. J Biol Chem 2006, 281:19881-19891. 10.1074/jbc.M600320200, 16670091.
22. Fan W, Imamura T, Sonoda N, Sears DD, Patsouris D, Kim JJ, Olefsky JM. FOXO1 transrepresses peroxisome proliferator-activated receptor gamma transactivation, coordinating an insulin-induced feed-forward response in adipocytes. J Biol Chem 2009, 284:12188-12197. 10.1074/jbc.M808915200, 2673287, 19246449.
23. Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell 2012, 149:1192-1205. 10.1016/j.cell.2012.05.012, 22682243.
24. Polvani S, Tarocchi M, Galli A. PPARgamma and Oxidative Stress: Con (beta) Catenating NRF2 and FOXO. PPAR Research 2012, 2012:641087. 3317010, 22481913.
25. Tamai K, Zeng X, Liu C, Zhang X, Harada Y, Chang Z, He X. A mechanism for Wnt coreceptor activation. Mol Cell 2004, 13:149-156. 10.1016/S1097-2765(03)00484-2, 14731402.
26. Chen S, Gai J, Wang Y, Li H. FoxO regulates expression of decidual protein induced by progesterone (DEPP) in human endothelial cells. FEBS Lett 2011, 585:1796-1800. 10.1016/j.febslet.2011.04.024, 21510935.
27. Kunze M, Neuberger G, Maurer-Stroh S, Ma J, Eck T, Braverman N, Schmid JA, Eisenhaber F, Berger J. Structural requirements for interaction of peroxisomal targeting signal 2 and its receptor PEX7. J Biol Chem 2011, 286:45048-45062. 10.1074/jbc.M111.301853, 3247985, 22057399.
28. Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 2002, 156:1051-1063. 10.1083/jcb.200108057, 2173473, 11901170.
29. DeLuca JG, Doebber TW, Kelly LJ, Kemp RK, Molon-Noblot S, Sahoo SP, Ventre J, Wu MS, Peters JM, Gonzalez FJ, Moller DE. Evidence for peroxisome proliferator-activated receptor (PPAR) alpha-independent peroxisome proliferation: effects of PPARgamma/delta-specific agonists in PPARalpha-null mice. Mol Pharmacol 2000, 58:470-476.
30. Chen T, Jin X, Crawford BH, Cheng H, Saafir TB, Wagner MB, Yuan Z, Ding G. Cardioprotection from oxidative stress in the newborn heart by activation of PPARgamma is mediated by catalase. Free Radic Biol Med 2012, 53:208-215. 10.1016/j.freeradbiomed.2012.05.014, 22609424.
31. Stepp MW, Folz RJ, Yu J, Zelko IN. The c10orf10 gene product is a new link between oxidative stress and autophagy. Biochimica et biophysica acta 2014, 1843:1076-1088. 10.1016/j.bbamcr.2014.02.003, 24530860.
32. Schrader M, Yoon Y. Mitochondria and peroxisomes: are the'big brother' and the'little sister' closer than assumed?. Bioessays 2007, 29:1105-1114. 10.1002/bies.20659, 17935214.
33. Kopnin PB, Agapova LS, Kopnin BP, Chumakov PM. Repression of sestrin family genes contributes to oncogenic Ras-induced reactive oxygen species up-regulation and genetic instability. Cancer Res 2007, 67:4671-4678. 10.1158/0008-5472.CAN-06-2466, 2657553, 17510393.
34. Scherz-Shouval R, Elazar Z. ROS, mitochondria and the regulation of autophagy. Trends Cell Biol 2007, 17:422-427. 10.1016/j.tcb.2007.07.009, 17804237.
35. Morris BJ. A forkhead in the road to longevity: the molecular basis of lifespan becomes clearer. J Hypertens 2005, 23:1285-1309. 10.1097/01.hjh.0000173509.45363.dd, 15942449.
36. Ragel BT, Couldwell WT, Gillespie DL, Jensen RL. Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis. Neurosurg Rev 2007, 30:181-187. discussion 187, 10.1007/s10143-007-0070-z, 17486380.
37. Bienert GP, Moller AL, Kristiansen KA, Schulz A, Moller IM, Schjoerring JK, Jahn TP. Specific aquaporins facilitate the diffusion of hydrogen peroxide across membranes. J Biol Chem 2007, 282:1183-1192. 10.1074/jbc.M603761200, 17105724.
38. Narath R, Lorch T, Greulich-Bode KM, Boukamp P, Ambros PF. Automatic telomere length measurements in interphase nuclei by IQ-FISH. Cytometry A 2005, 68:113-120.
39. Gross N, Favre S, Beck D, Meyer M. Differentiation-related expression of adhesion molecules and receptors on human neuroblastoma tissues, cell lines and variants. Int J Cancer 1992, 52:85-91. 10.1002/ijc.2910520116, 1354203.
40. Grignani F, Kinsella T, Mencarelli A, Valtieri M, Riganelli D, Grignani F, Lanfrancone L, Peschle C, Nolan GP, Pelicci PG. High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res 1998, 58:14-19.
41. Ausserlechner MJ, Obexer P, Deutschmann A, Geiger K, Kofler R. A retroviral expression system based on tetracycline-regulated tricistronic transactivator/repressor vectors for functional analyses of antiproliferative and toxic genes. Mol Cancer Ther 2006, 5:1927-1934. 10.1158/1535-7163.MCT-05-0500, 16928812.
42. Ausserlechner MJ, Salvador C, Deutschmann A, Bodner M, Viola G, Bortolozzi R, Basso G, Hagenbuchner J, Obexer P. Therapy-resistant acute lymphoblastic leukemia (ALL) cells inactivate FOXO3 to escape apoptosis induction by TRAIL and Noxa. Oncotarget 2013, 4:995-1007. 3759677, 23828551.
43. Dijkers PF, Birkenkamp KU, Lam EW, Thomas NS, Lammers JW, Koenderman L, Coffer PJ. FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity. J Cell Biol 2002, 156:531-542. 10.1083/jcb.200108084, 2173339, 11815629.
44. Schmidt S, Rainer J, Riml S, Ploner C, Jesacher S, Achmuller C, Presul E, Skvortsov S, Crazzolara R, Fiegl M, Raivio T, Jänne OA, Geley S, Meister B, Kofler R. Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia. Blood 2006, 107:2061-2069. 10.1182/blood-2005-07-2853, 16293608.
45. Wu RAI Z, Gentleman R, Martinez-Murillo F, Spencer F. A Model Based Background Adjustement for Oligonucleotide Expression Arrays. J Am Stat Assoc 2004, 99:909-917.
46. Hagenbuchner J, Ausserlechner MJ, Porto V, David R, Meister B, Bodner M, Villunger A, Geiger K, Obexer P. The anti-apoptotic protein BCL2L1/Bcl-xL is neutralized by pro-apoptotic PMAIP1/Noxa in neuroblastoma, thereby determining bortezomib sensitivity independent of prosurvival MCL1 expression. J Biol Chem 2010, 285:6904-6912. 10.1074/jbc.M109.038331, 2844140, 20051518.